{
    "Trade/Device Name(s)": [
        "ONLINE TDM Phenytoin - Free Phenytoin application"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K230161",
    "Predicate Device Reference 510(k) Number(s)": [
        "K952555"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MOJ"
    ],
    "Summary Letter Date": "March 30, 2023",
    "Summary Letter Received Date": "January 20, 2023",
    "Submission Date": "January 19, 2023",
    "Regulation Number(s)": [
        "21 CFR 862.3350"
    ],
    "Regulation Name(s)": [
        "Diphenylhydantoin test system"
    ],
    "Analyte Class(es)": [
        "toxicology",
        "tdm"
    ],
    "Analyte(s)": [
        "Free Phenytoin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Lithium heparin plasma",
        "K2-EDTA plasma",
        "K3-EDTA plasma"
    ],
    "Specimen Container(s)": [
        "Serum tube",
        "Lithium heparin tube",
        "K2-EDTA tube",
        "K3-EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "cobas c systems",
        "cobas c 503 analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Kinetic Interaction of Microparticles in Solution (KIMS)",
        "Ultrafiltration"
    ],
    "Methodologies": [
        "Immunoassay",
        "Ultrafiltration"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for the ONLINE TDM Phenytoin - Free Phenytoin application, an in vitro immunoassay for quantitative measurement of free phenytoin in serum and plasma using cobas c systems.",
    "Indications for Use Summary": "In vitro test for quantitative determination of free phenytoin in human serum and plasma on cobas c systems to monitor levels and ensure appropriate therapy.",
    "fda_folder": "Toxicology"
}